E d u c a t i o n a n d R e s e a r c h P r o g r a m s (Amount granted: more than 10 million yen)

M E X T : Ministry of Education, Culture, Sports, Science and Technology
M E T I : Ministry of Economy, Trade and Industry
J S T : Japan Science and Technology Agency
A M E D : Japan Agency for Medical Research and Development

History
Philosophy andObjectives
Past and Present
Deans andDirectors

Data as of July 1, 2021■■Promotion Plan for the Platform of Human Resource Development for Cancer (MEXT)

Funding
PeriodPartner Organizations

Program

2017-2021

Sapporo Medical UniversityHokkaido University
Asahikawa Medical University
Health Sciences University of Hokkaido

Hokkaido Promotion Plan for
the Platform of Human
Resource Development forCancer

Responsible Department

Faculty of Medicine■■Project for Enhancing the Human Resource Development Function at Universities, Graduate Schools and 

Professors
EmeritiAffiliated Hospitals (Problem-Solving Oriented Training Program for Advanced Medical Personnel) (MEXT)
Funding
PeriodHonor Roll

2019-2021

Partner Organizations

ProjectHuman Resource Development
Specialized in Promoting theUse of Donated Cadaver inClinical Medicine

Hokkaido University
Kyoto University
Chiba University

Research Director
SHICHINOHE Toshiaki, M.D., Ph.D.
Associate Professor, Department ofGastroenterological Surgery II■■Industry-Academia Joint Project of Human Resources Development for the Acceleration of AI Research Development

Students

Organizations /Financesin the Field of Healthcare (MEXT)
Funding
Period2020-2024

Partner Organizations

Tohoku University
Hokkaido University
Okayama University

International
Affairs
Endowed Depts.
and Industry
Creation Depts.
Education andResearchSystem

2020-2022

Human Resources
Development Program “Cutting
Edge AI Research Development
for the Solution of Global ×
Local Medical Problems”

KUDO Kohsuke, M.D., Ph.D.
Professor, Department of Diagnostic Imaging

ProjectInternational Standardization Relating to the Data for the Prediction About
Prognosis After Radiotherapy

Leader/R&D Chief
SHIRATO Hiroki, M.D., Ph.D.
Director, Global Center for Biomedical
Science and Engineering■■JST PRESTO

Funding
Period2021-2022

ProgramInter-cell Interactions Responsible for Sleep and Hibernation

Research Director
NORIMOTO Hiroaki, Ph.D.
Associate Professor, Department of Cellularand Molecular Pharmacology■■COI STREAM (JST)Funding
Period2013-2021

CampusResearch Director■■Activity in International Standardization in the Governmental Strategic Field (METI)

Funding
Period55

Project

Name of the Site
Innovative Food & Healthcare MASTER

LeaderProject Leader: YOSHINO Masanori, Hitachi, Ltd.
Research Leader: TAMAKOSHI Akiko, M.D., Ph.D.
Professor, Department of Public Health

■■Project for the Advancement of R & D and Strengthening of the Development System for Medical Devices and Related

2017-2021

Development of Intraoperative Prompt Therapeutic Decision Support System
During Quantum Beam Surgery (QBS) and Surgical Operation AfterRadiotherapy

Research Representative
SHIRATO Hiroki, M.D., Ph.D.
Director, Global Center for Biomedical
Science and Engineering

Philosophy andObjectives

Program■■Research Program on Emerging and Re-emerging Infectious Diseases (AMED)

Funding
Period2020-2021

ProgramEstablishment of an In Vivo SARS-CoV-2 Infection System That Can be
Examined at P2 Facilities

Research Representative
FUKUHARA Takasuke, M.D., Ph.D.
Professor, Department of Microbiology andImmunology

Past and PresentDeans andDirectors

Funding
PeriodHistory

Products (AMED)

Program

2018-2021

Study on the Mechanism of Inflammatory Memory in Intestinal Regeneration

TANIGUCHI Koji, M.D., Ph.D.
Professor, Department of Pathology

2018-2021

Study of the Cellular and Cell Adhesion Molecule Mechanisms Underlying
Peripheral Nerve Axon Regeneration

KADOYA Ken, M.D., Ph.D.
Specially Appointed Associate Professor,
Department of Advanced Research forLocomotor System

Research Representative

Honor RollFunding
PeriodProfessors
Emeriti■■Advanced Research & Development Programs for Medical Innovation (AMED)KUDO Kohsuke, M.D., Ph.D.
Professor, Department of Diagnostic Imaging

2020-2022

Elucidation of the Pathogenesis and Risk Factors of Bullous Pemphigoid

UJIIE Hideyuki, M.D., Ph.D.
Professor, Department of Dermatology

2021-2023

An Investigator-initiated Clinical Trial of Spinocerebellar Ataxia Type 1 (SCA1)
Gene Therapy Based on Molecular Mechanisms

YABE Ichiro, M.D., Ph.D.
Professor, Department of Neurology■■Practical Research for Innovative Cancer Control (AMED)

Funding
PeriodProgram

2019-2021

Efficacy of Rikkunshito on Chemotherapy-Induced Nausea and Vomiting in
Patients with Uterine Corpus or Cervical Cancer Treated with
Cisplatin-Based Regimen - Placebo-Controlled, Double-Blind,
Randomized Confirmatory StudyWATARI Hidemichi, M.D., Ph.D.
Professor, Department of Obstetrics andGynecology

2020-2022

Establishment of Standard Therapy for Acute Lymphoblastic Leukemia inChildren

MANABE Atsushi, M.D., Ph.D.
Professor, Department of Pediatrics

2020-2022

The Development of New Treatment of Superselective Intra-Arterial Infusionof Cisplatin and Concomitant Radiotherapy for Patients with Locally
Advanced Maxillary Sinus Cancer

HOMMA Akihiro, M.D., Ph.D.
Professor, Department of OtolaryngologyHead and neck Surgery

Research Representative■■Research Program on Hepatitis / Program for Basic and Clinical Research on Hepatitis (AMED)

Funding
PeriodProgramResearch Representative

2020-2022

Screening of Prognostic Biomarker by Comprehensive Serum and Liver Tissue
Glycomics

SAKAMOTO Naoya, M.D., Ph.D.
Professor, Department of Gastroenterologyand Hepatology

Students

Early MRI Diagnosis of Amyotrophic Lateral Sclerosis using Stable Isotope ofOxygen-17

InternationalAffairs

2020-2022

Endowed Depts.
and Industry
Creation Depts.

Research Representative

Education andResearchSystem

ProgramCampusFunding
PeriodOrganizations /Finances■■Practical Research Project for Rare/Intractable Diseases (AMED)

56

■■Research Center Network for Realization of Regenerative Medicine

Past and Present
Deans andDirectors

Philosophy andObjectives

History

The Program for Technological Innovation of Regenerative Medicine (AMED)
Funding
PeriodProgramResearch Representative

2020-2022

Development of Cell Therapy to Treat Combined Lumbar Canal Stenosis
Using Highly-Pure Allogenic Bone Marrow-Derived Mesenchymal Stem Cells(REC)

SUDO Hideki, M.D., Ph.D.
Specially Appointed Professor, Departmentof Advanced Medicine for Spine and Spinal
Cord Disorders■■Project for Cancer Research and Therapeutic Evolution (P-CREATE) (AMED)

Funding
Period2020-2021

ProgramResearch Representative

Study of Regulation of Tumor Heterogeneity by Biomaterial

TANAKA Shinya, M.D., Ph.D.
Professor, Department of Cancer Pathology

Honor Roll

Professors
Emeriti■■Japan Program for Infectious Diseases Research and Infrastructure (AMED)

Funding
PeriodProgramResearch Representative

2020-2022

Elucidation of Properties and Evolutionary Mechanisms of Virome Involved inProgression of Pathogenesis

FUKUHARA Takasuke, M.D., Ph.D.
Professor, Department of Microbiology andImmunology■■Special Expenditures (MEXT)

Campus

Education andResearch
SystemEndowed Depts.
and Industry
Creation Depts.

InternationalAffairsStudents

Organizations /Finances

Funding
Period57

2021-2025

Faculties

Faculty of Medicine

Project
Project for the Promotion ofCause of Death Investigation
and Comprehensive Human
Resources Development
through Multi-disciplinary
Collaboration

Leader

HATAKEYAMA Shigetsugu, M.D., Ph.D.
Dean